Literature DB >> 14765269

Clinical implication of idiopathic plasmacytic lymphadenopathy with polyclonal hypergammaglobulinemia: a report of 16 cases.

Masaru Kojima1, Shigeo Nakamura, Kazuhiko Shimizu, Hideaki Itoh, Yuko Yamane, Kayoko Murayama, Hiroshi Tanaka, Shiro Sugihara, Shunichi Shimano, Noriyuki Sakata, Nobuhide Masawa.   

Abstract

Idiopathic plasmacytic lymphadenopathy (IPL) with polyclonal hyperimmunoglobulinemia is considered identical to multicentric Castleman's disease (MCD) reported in western countries. Clinically, both IPL and MCD are characterized by multicentric lymphadenopathy, prominent polyclonal hypergammaglobulinemia, elevated erythrocyte sedimentation rate, elevated serum interleukin-6 concentration, bone marrow plasmacytosis, and various abnormal laboratory data such as anemia and positive autoantibodies. However, IPL has a significantly better 5-year survival rate than that of MCD. Moreover, none of the present 16 cases developed Kaposi's sarcoma or B-cell lymphoma. Histologically, the interfollicular area contains a sheet of polytypic mature plasma cells in both IPL and MCD. In MCD, the majority of lymphoid follicles had hyaline-vascular germinal centers. However, lymphoid follicles of IPL usually exhibit a hyperplastic germinal center. Immunostaining also demonstrated a normal/reactive follicular dendritic cell network pattern in the germinal center of IPL. Moreover, there were no human herpes virus-8-positive cells detected by immunohistochemistry. The overall clinicopathologic and immunohistochemical findings of our 16 cases suggest that IPL is distinct from MCD reported in Western countries.

Entities:  

Mesh:

Year:  2004        PMID: 14765269     DOI: 10.1177/106689690401200104

Source DB:  PubMed          Journal:  Int J Surg Pathol        ISSN: 1066-8969            Impact factor:   1.271


  5 in total

Review 1.  Multicentric Castleman disease: Where are we now?

Authors:  Hao-Wei Wang; Stefania Pittaluga; Elaine S Jaffe
Journal:  Semin Diagn Pathol       Date:  2016-05-16       Impact factor: 3.464

Review 2.  Multicentric Castleman's disease: a challenging diagnosis.

Authors:  Györgyi Műzes; Ferenc Sipos; Judit Csomor; Lídia Sréter
Journal:  Pathol Oncol Res       Date:  2013-03-21       Impact factor: 3.201

3.  Castleman disease and TAFRO syndrome: To improve the diagnostic consciousness is the key.

Authors:  Qian-Yun Zhou
Journal:  World J Clin Cases       Date:  2022-02-16       Impact factor: 1.337

4.  Idiopathic multicentric Castleman disease with positive antiphospholipid antibody: atypical and undiagnosed autoimmune disease?

Authors:  Yoshito Nishimura; Asami Nishikori; Haruki Sawada; Torrey Czech; Yuki Otsuka; Midori Filiz Nishimura; Hiroki Mizuno; Naoki Sawa; Shuji Momose; Kumiko Ohsawa; Fumio Otsuka; Yasuharu Sato
Journal:  J Clin Exp Hematop       Date:  2022-03-05

5.  Idiopathic plasmacytic lymphadenopathy: A conceptual history along with a translation of the original Japanese article published in 1980.

Authors:  Kengo Takeuchi
Journal:  J Clin Exp Hematop       Date:  2022
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.